STAT October 17, 2024
Mario Aguilar

Blue Note’s failure holds lessons for other digital therapeutics startups

The bad news didn’t come all at once for Blue Note Therapeutics, but a final denial from the Food and Drug Administration in January proved to be the final blow.

In late 2023, after a rejection from the agency earlier in the year, Blue Note had made a last...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, FDA, Govt Agencies, Technology
Tech Troubles: Digital Era Downsides (And How To Solve Them)
Florida health system rolls out virtual nursing tech to 1K rooms
Virtual care could cut US medical claims costs
AAHPM Board President: Telehealth Access ‘Critical’ for Hospice Patients
STAT+: How invisible medical groups are powering telehealth’s GLP-1 ‘gold rush’

Share This Article